MedPath

Dry Needling Versus Percutaneous Electrolysis in Lumbar Multifidus Muscles in Patients With Chronic Low Back Pain.

Not Applicable
Not yet recruiting
Conditions
Chronic Low-back Pain
Interventions
Other: Dry needling
Other: Percutaneous electrolysis
Registration Number
NCT06505161
Lead Sponsor
University of Alcala
Brief Summary

The aim of this study is to evaluate the reduction of pain of two different treatments in patients with chronic low back pain. Patients were divided in two groups. The control group will receive DN treatment, and the experimental group will receive PE, both in the lumbar multifidus muscles.

Detailed Description

Background: Low back pain is one of the most common health problems and a leading cause of disability and absence from work. Between 70% and 80% of adults will experience an episode of low back pain and approximately 10.0% of them will become chronic. This has a direct impact on the lumbar stabilizing muscles, giving rise to both structural and functional changes. Among the different treatment options, it has been observed that both dry needling (DN) and percutaneous electrolysis (PE) are effective techniques in the management of musculoskeletal pain.

Aim: To evaluate whether the reduction of pain after the application of PE is superior to the one obtained with DN.

Methods: A single-blind randomized clinical trial will be conducted in patients with chronic low back pain. The subjects will be divided into two groups. The control group will receive DN treatment, and the experimental group will receive PE, both in the lumbar multifidus muscles. The study variables will be: pain (VAS), disability index (Oswestry Scale), fear of movement (TSK-11SV) and quality of life (SF-12). The measurements will be assessed before, right after and 7 days after a single intervention.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Low back pain ≥ 3 months.
  • Age between 30 and 60 years old.
  • Not being receiving other physical therapy
Exclusion Criteria
  • Diagnosis of specific lumbar pathology.
  • History of previous lumbar surgery.
  • Treatment with corticosteroids, anti-inflammatory or antibiotic medication in recent weeks.
  • Oncological processes, febrile symptoms or thrombophlebitis.
  • Skin conditions.
  • Belonephobia.
  • Pacemaker.
  • Pregnancy.
  • Patients with neurological pathology

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dry needling groupDry needlingThe dry needling group will recibe a dry needling treatment with the Hong technique.
Percutaneous electrolysis groupPercutaneous electrolysisThe percutaneous electrolysis grupos will recibe a tratement of galvanic current at 1.5mA, with 3-5 impacts, for 3-5 seconds in the low back multifiud muscles.
Primary Outcome Measures
NameTimeMethod
Pain intensity. Visual analogue scale.At baseline, at 1 week after the last intervention, and 6-month follow-up period

A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain

Secondary Outcome Measures
NameTimeMethod
Disability. Oswestry Low Back Pain Disability IdexAt baseline, at 1 week after the last intervention, and 6-month follow-up period

It has 10 items associated to activities of daily living, each item has a punctuation from 0 to 5 points

Quality of life. SF-12 Health questionnaire.At baseline, at 1 week after the last intervention, and 6-month follow-up period

SF-12 Health questionnaire scores range from 0 to 100% and indicate the self-perceived health-related quality of life

Fear of Movement. Tampa Scale of kinesiophobia (TSK-11SV)At baseline, at 1 week after the last intervention, and 6-month follow-up period

Is a 11-item questionnaire that measures the fear of movement and (re)injury.

Trial Locations

Locations (1)

Campus Científico-Tecnológico UAH. Av. de León, 3A

🇪🇸

Alcalá De Henares, Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath